MeSH D017029 - complex partial epilepsy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Vigabatrin | Vigabatrin | 2019-01-14 | |||
| Cipla | Vigabatrin | Vigabatrin | 2019-12-03 | |||
| Aurobindo Pharma | Vigabatrin | Vigabatrin | 2021-09-29 | |||
| Dr Reddys Laboratories | Vigabatrin | Vigabatrin | 2018-11-20 | |||
| Zydus Therapeutics | Vigabatrin | Vigabatrin | 2023-03-02 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/1
Phase 3
70%7/10
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use